Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 2
1980 4
1981 3
1982 2
1983 1
1984 4
1985 2
1986 2
1987 4
1988 2
1989 4
1990 4
1991 2
1992 2
1993 1
1994 2
1995 2
1996 1
1997 3
1998 2
1999 1
2000 2
2001 1
2003 2
2006 2
2008 1
2009 1
2010 3
2011 5
2012 1
2014 2
2017 1
2018 2
2019 2
2020 9
2021 6
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Erythema ab igne.
Naldi L, Berni A, Pimpinelli N, Poggesi L. Naldi L, et al. Among authors: poggesi l. Intern Emerg Med. 2011 Apr;6(2):175-6. doi: 10.1007/s11739-010-0400-y. Epub 2010 May 8. Intern Emerg Med. 2011. PMID: 20454870 No abstract available.
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.
Scoccianti S, Francolini G, Carta GA, Greto D, Detti B, Simontacchi G, Visani L, Baki M, Poggesi L, Bonomo P, Mangoni M, Desideri I, Pallotta S, Livi L. Scoccianti S, et al. Among authors: poggesi l. Crit Rev Oncol Hematol. 2018 Jun;126:80-91. doi: 10.1016/j.critrevonc.2018.03.024. Epub 2018 Mar 31. Crit Rev Oncol Hematol. 2018. PMID: 29759570 Review.
A challenging multifactorial migraine with aura.
Naldi L, De Stefano M, Berni A, Torri M, Poggesi L. Naldi L, et al. Among authors: poggesi l. Intern Emerg Med. 2014 Mar;9(2):201-5. doi: 10.1007/s11739-013-1038-3. Epub 2014 Jan 14. Intern Emerg Med. 2014. PMID: 24419740 No abstract available.
T-Lymphocyte-Based Renin Angiotensin System in Obesity.
Coppo M, Bandinelli M, Chiostri M, Poggesi L, Boddi M. Coppo M, et al. Among authors: poggesi l. Am J Med Sci. 2019 Jul;358(1):51-58. doi: 10.1016/j.amjms.2019.03.008. Epub 2019 Mar 28. Am J Med Sci. 2019. PMID: 31084908
Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?
Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Berni A, et al. Among authors: poggesi l. J Endocrinol Invest. 2020 Aug;43(8):1137-1139. doi: 10.1007/s40618-020-01301-w. Epub 2020 May 25. J Endocrinol Invest. 2020. PMID: 32451971 Free PMC article. No abstract available.
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.
Vivarelli E, Matucci A, Lucenteforte E, Bormioli S, Virgili G, Trotta M, Spinicci M, Bartoloni A, Zammarchi L, Peris A, Pieralli F, Lavorini F, Fontanari P, Morettini A, Nozzoli C, Poggesi L, Rossi O, Annunziato F, Almerigogna F, Vultaggio A. Vivarelli E, et al. Among authors: poggesi l. Panminerva Med. 2023 Dec;65(4):473-478. doi: 10.23736/S0031-0808.21.04523-7. Epub 2022 Mar 11. Panminerva Med. 2023. PMID: 35274908
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
Vannucchi AM, Sordi B, Morettini A, Nozzoli C, Poggesi L, Pieralli F, Bartoloni A, Atanasio A, Miselli F, Paoli C, Loscocco GG, Fanelli A, Para O, Berni A, Tassinari I, Zammarchi L, Maggi L, Mazzoni A, Scotti V, Falchetti G, Malandrino D, Luise F, Millotti G, Bencini S, Capone M, Piccinni MP, Annunziato F, Guglielmelli P; RUXO-COVID Study Group. Vannucchi AM, et al. Among authors: poggesi l. Leukemia. 2021 Apr;35(4):1121-1133. doi: 10.1038/s41375-020-01018-y. Epub 2020 Aug 19. Leukemia. 2021. PMID: 32814839 Free PMC article. Clinical Trial.
88 results